Results 81 to 90 of about 95,295 (264)

Anticoagulation Status and Outcome in Cerebral Venous Thrombosis: A Single-Center Retrospective Study from South India

Annals of Indian Academy of Neurology
Background and Objectives: Early initiation and maintenance of anticoagulation appears to be the mainstay of treatment of cerebral venous thrombosis (CVT), but the evidence supporting the intensity and duration of anticoagulation is limited.
Deepak Menon, Manisha Gupta, Sangeeth Thuppanattumadam Ananthasubramanian, Karthik Kulanthaivelu, Pritam Raja, Subasree Ramakrishnan, Sangeetha Seshagiri Karnam, Jitender Saini, PR Srijithesh, Girish B Kulkarni   +9 more
doaj   +1 more source

Risk factors for intrapartum stillbirth and the survival probabilities of fetuses among pregnant women with complications: Secondary analysis of data from a multicenter prospective cohort study in India

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To identify the risk factors for intrapartum stillbirth and examine whether these are different from that of antepartum stillbirth, and investigate the survival probabilities of fetuses by gestational age in high‐risk pregnancies. Methods We conducted a secondary data analysis of a hospital‐based cohort study from India, including ...
Yebeen Ysabelle Boo, Saswati S. Choudhury, Farzana Zahir, Gitanjali Deka, Amrit K. Bora, Shakuntala Chhabra, Pramod Kumar, Pranabika Mahanta, Bina Minz, Anjali Rani, Sereesha Rao, Indrani Roy, Carolin Solomi V., Ashok Verma, Swapna Kakoty, Omesh Kumar Bharti, Rupanjali Deka, Charles Opondo, Tuck Seng Cheng, Jennifer J. Kurinczuk, Manisha Nair, on behalf of the MaatHRI collaborators   +21 more
wiley   +1 more source

Hepatic Encephalopathy and Age Were Assessed to Ameliorate the Underestimation of the Model for End‐Stage Liver Disease Score in Patients With Acute‐on‐Chronic Liver Failure

iNew Medicine, EarlyView.
This study demonstrates that the model for end‐stage liver disease (MELD) score significantly underestimates 90‐day mortality in acute‐on‐chronic liver failure (ACLF) patients (AUC: 0.556) compared to non‐ACLF patients (area under the receiver operating characteristic curve [AUC]: 0.848).
Guanghou Chen, Qifei Guan, Yufeng Gao, Zhenhua Zhang, Hongchuan Zhao, Beicheng Sun   +5 more
wiley   +1 more source

When new therapies meet old challenges: tirzepatide–warfarin interaction in a mechanical mitral valve patient

European Journal of Case Reports in Internal Medicine
Tirzepatide is a medication capable of controlling blood glucose levels through the dual agonism of GIP and GLP-1 receptors. In particular, GLP-1 reduces food intake and delays gastric emptying. We report the case of a 66-year-old woman hospitalised with
Raffaele Natale, Annadora Morena, Luca Maria Capece, Sofia Donnarumma, Ermenegilda Pagano, Fabrizio Pasanisi, Lidia Santarpia   +6 more
doaj   +1 more source

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai, Hirohiko Aikawa, Yoshiaki Morita, Keiko Ohta‐Ogo, Teruo Noguchi   +4 more
wiley   +1 more source

Hospital Volume and Operative Mortality in Pancreaticoduodenectomy and Hepatectomy: Analysis of the National Clinical Database in Japan

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background/Purpose This study evaluated the association between institutional advanced hepatobiliary‐pancreatic (HBP) surgical volume and operative mortality for pancreaticoduodenectomy (PD) and advanced hepatectomy using data from the Japanese National Clinical Database.
Yoshitaro Shindo, Hideki Endo, Hiroyuki Yamamoto, Hidenori Takahashi, Shigeru Marubashi, Atsushi Nanashima, Itaru Endo, Hideki Ueno, Ken Shirabe, Masafumi Nakamura, Hiroaki Nagano, Masayuki Ohtsuka   +11 more
wiley   +1 more source

Sacubitril/Valsartan and elevated prothrombin time/international normalized ratio in the absence of anticoagulant therapy: a newly recognized potential adverse drug reaction

European Journal of Case Reports in Internal Medicine
Introduction: Sacubitril/valsartan is the first approved angiotensin receptor–neprilysin inhibitor (ARNI) and a cornerstone therapy for heart failure with reduced ejection fraction (HFrEF).
Tanuj Diyora, Ayush Ranajn
doaj   +1 more source

Using Labs Wisely: A collaboration between Choosing Wisely Canada and over 150 Canadian hospitals

Journal of Hospital Medicine, EarlyView.
Abstract Background Many in‐hospital laboratory tests are unnecessary. Unnecessary testing is associated with patient harm, fiscal inefficiency, and environmental waste. Objectives In 2021, Choosing Wisely Canada launched the Using Labs Wisely (ULW) hospital collaborative to (1) build national expertise on reducing unnecessary testing, (2) share ...
Thomas Bodley, Bilal Shakir, Gillian Hurwitz, Adina Weinerman, Lisha Lo, Saranya Arnoldo, Chloe Chow, Janet Simons, Wendy Levinson   +8 more
wiley   +1 more source

Warfarin and Polypharmacy Challenges in Sudan: Drug Interactions in Patient Cohort

Integrated Pharmacy Research and Practice
Ahmed AA Omer,1 Abdal Mahmoud Elsiddig,2 Imad M Taj1 1Department of Pharmacology Faculty of Pharmacy, University of Gezira, Wad Medani, Gezira State, 21111, Sudan; 2Medani Heart Centre, Wad Medani, Gezira State, 550, SudanCorrespondence: Ahmed AA Omer ...
Omer AAA, Elsiddig AM, Taj IM
doaj  

Understanding and interpreting composite outcomes in clinical research

Journal of Hospital Medicine, EarlyView.
Abstract Composite outcomes combine multiple endpoints into a single measure. They can capture overall treatment effects and increase statistical power, but have important interpretive challenges. Components of the outcome may vary in clinical importance, frequency, and treatment effect.
Mari Takashima, Brett Dyer, Amanda J. Ullman, Robert S. Ware   +3 more
wiley   +1 more source